Agency's top side not happy with slow change

Share this article:
FDA commissioner Margaret Hamburg and principal deputy commissioner Joshua Sharfstein say they are concerned by how long it takes to make changes in the agency. Their comments were reported in a New England Journal of Medicine assessment of their first year at the helm of FDA.
Hamburg told a February Institute of Medicine meeting that despite her past experiences working in government, she was struck by how long it takes to make a change at FDA. “You feel it differently at FDA —how long it takes to move things through the system,” she said. “The process of regulation does not allow you to respond in a timely way to emerging science or to other important emerging concerns.”
Sharfstein put it more bluntly: “I keep a list of things that I wish were moving faster and a list of things moving at just the right speed,” he said, “and there's nothing on the second list.”
The report said that Hamburg and Sharfstein have been trying to find ways to make FDA more nimble and proactive.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?